CA2961356C — Heterocyclic compounds and their uses in modulating bromodomain and for treating diseases or conditions relevant thereto
Assigned to Plexxikon Inc · Expires 2023-03-07 · 3y expired
What this patent protects
The present invention provides heterocyclic compounds of formula (I), pharmaceutical compositions containing such a compound and their therapeutic uses in modulating bromodomain and/or in treatment of, for example, cancer, autoimmune condition, inflammatory condition, or a combin…
USPTO Abstract
The present invention provides heterocyclic compounds of formula (I), pharmaceutical compositions containing such a compound and their therapeutic uses in modulating bromodomain and/or in treatment of, for example, cancer, autoimmune condition, inflammatory condition, or a combination thereof. (see formula I)
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.